» Articles » PMID: 23002075

Hypoxia-induced Endothelial CX3CL1 Triggers Lung Smooth Muscle Cell Phenotypic Switching and Proliferative Expansion

Abstract

Distal arterioles with limited smooth muscles help maintain the high blood flow and low pressure in the lung circulation. Chronic hypoxia induces lung distal vessel muscularization. However, the molecular events that trigger alveolar hypoxia-induced peripheral endothelium modulation of vessel wall smooth muscle cell (SMC) proliferation and filling of nonmuscular areas are unclear. Here, we investigated the role of CX3CL1/CX3CR1 system in endothelial-SMC cross talk in response to hypoxia. Human lung microvascular endothelial cells responded to alveolar oxygen deficiency by overproduction of the chemokine CX3CL1. The CX3CL1 receptor CX3CR1 is expressed by SMCs that are adjacent to the distal endothelium. Hypoxic release of endothelial CX3CL1 induced SMC phenotypic switching from the contractile to the proliferative state. Inhibition of CX3CR1 prevented CX3CL1 stimulation of SMC proliferation and monolayer expansion. Furthermore, CX3CR1 deficiency attenuated spiral muscle expansion, distal vessel muscularization, and pressure elevation in response to hypoxia. Our findings indicate that the capillary endothelium relies on the CX3CL1-CX3CR1 axis to sense alveolar hypoxia and promote peripheral vessel muscularization. These results have clinical significance in the development of novel therapeutics that target mechanisms of distal arterial remodeling associated with pulmonary hypertension induced by oxygen deficiency that is present in people living at high altitudes and patients with obstructive lung diseases.

Citing Articles

New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.

Su X, Sun Y, Dai A Apoptosis. 2025; .

PMID: 39979525 DOI: 10.1007/s10495-025-02086-0.


The role of microglia in neuronal and cognitive function during high altitude acclimatization.

Hatch K, Lischka F, Wang M, Xu X, Stimpson C, Barvir T Sci Rep. 2024; 14(1):18981.

PMID: 39152179 PMC: 11329659. DOI: 10.1038/s41598-024-69694-9.


Exploring the pathogenesis of pulmonary vascular disease.

Ejikeme C, Safdar Z Front Med (Lausanne). 2024; 11:1402639.

PMID: 39050536 PMC: 11267418. DOI: 10.3389/fmed.2024.1402639.


VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis.

Wolf M, Madden M, Arner E, Bader J, Ye X, Vlach L J Clin Invest. 2024; 134(8.

PMID: 38618956 PMC: 11014672. DOI: 10.1172/JCI173934.


The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications.

Zhao H, Song J, Li X, Xia Z, Wang Q, Fu J Front Immunol. 2024; 15:1374506.

PMID: 38529271 PMC: 10962924. DOI: 10.3389/fimmu.2024.1374506.


References
1.
Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Godot V, Capel F . Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J. 2006; 29(5):937-43. DOI: 10.1183/09031936.00104706. View

2.
Larsen K, Yndestad A, Sjaastad I, Loberg E, Goverud I, Halvorsen B . Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation. Am J Physiol Lung Cell Mol Physiol. 2011; 301(1):L50-9. DOI: 10.1152/ajplung.00048.2010. View

3.
Santos S, Peinado V, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R . Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002; 19(4):632-8. DOI: 10.1183/09031936.02.00245902. View

4.
Nicolls M, Taraseviciene-Stewart L, Rai P, Badesch D, Voelkel N . Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J. 2005; 26(6):1110-8. DOI: 10.1183/09031936.05.00045705. View

5.
Ryu J, Lee C, Hong K, Shin J, Lim S, Park C . Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res. 2007; 78(2):333-40. DOI: 10.1093/cvr/cvm067. View